Evidence map›Paper›PMID 32876838›Full record

ArticleEuropean radiology2021

Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.

Mateusz Śpiewak, Mariusz Kłopotowski, Natalia Ojrzyńska, Joanna Petryka-Mazurkiewicz, Barbara Miłosz-Wieczorek, Łukasz Mazurkiewicz, Jacek Grzybowski, Zofia Bilińska, Adam Witkowski, Magdalena Marczak

Abstract read
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mateusz ŚpiewakMagnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland. mspiewak@ikard.pl.ORCID http://orcid.org/0000-0002-2393-4194
Mariusz KłopotowskiDepartment of Cardiology and Interventional Angiology, National Institute of Cardiology, Warsaw, Poland.
Natalia OjrzyńskaDepartment of Cardiomyopathies, National Institute of Cardiology, Warsaw, Poland.
Joanna Petryka-MazurkiewiczDepartment of Coronary Artery Disease and Structural Heart Diseases, National Institute of Cardiology, Warsaw, Poland.
Barbara Miłosz-WieczorekMagnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland.
Łukasz MazurkiewiczDepartment of Cardiomyopathies, National Institute of Cardiology, Warsaw, Poland.
Jacek GrzybowskiDepartment of Cardiomyopathies, National Institute of Cardiology, Warsaw, Poland.
Zofia BilińskaUnit for Screening Studies in Inherited Cardiovascular Diseases, National Institute of Cardiology, Warsaw, Poland.
Adam WitkowskiDepartment of Cardiology and Interventional Angiology, National Institute of Cardiology, Warsaw, Poland.
Magdalena MarczakMagnetic Resonance Unit, National Institute of Cardiology, ul. Alpejska 42, 04-628, Warsaw, Poland.

Funding

Ministerstwo Nauki i Szkolnictwa Wyższego IP 2014 0477 73National Institute of Cardiology 4.5/V/17
6 · The paper itself

Abstract

objectivesTo assess the value of cardiac MRI in comparison to echocardiography in consecutive patients with previously diagnosed and new suspected hypertrophic cardiomyopathy (HCM).

methodsAll MRI studies of patients with HCM or suspected disease performed at our centre within a 10-year time period were evaluated. Initial diagnoses (echocardiography-based) and final (MRI-based) diagnoses were compared in subgroups, and the discrepancies were recorded.

resultsA total of 1006 subjects with HCM or suspected HCM were identified (61% males, 39% females; median age, 49.1 years; interquartile range, 34.9-60.4). In 12 (2.2%) out of 550 patients with known HCM, MRI indicated a diagnosis other than HCM, including but not limited to the subaortic membrane (n = 1, 8.3%) or mild left ventricular hypertrophy (n = 5, 41.7%). Among all patients with suspected HCM (n = 456), MRI diagnosis was different from HCM in 5.3% (n = 24) of patients. In an additional 20.4% of patients (n = 93), no significant hypertrophy was present. In total, among patients with suspected HCM, MRI led to clear HCM diagnosis in 204 (44.7%) patients. Among patients with a history of uncontrolled hypertension suspected of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis, namely, 29.6% compared with 13.8% in the remaining groups of patients with suspected HCM (p = 0.0001).

conclusionsIn a small but important group of patients with ultrasound-based HCM, cardiac MRI can diagnose previously unknown conditions and/or refute suspected cardiomyopathy. The diagnostic yield of MRI when compared to echocardiography in patients suspected of having HCM is 44.7%. KEY POINTS: • Out of 550 patients previously diagnosed with echocardiography but without magnetic resonance imaging (MRI) as having hypertrophic cardiomyopathy (HCM), we diagnosed a different disease in 12 (2.2%) patients using MRI. • Among patients with suspected HCM based on echocardiography, MRI led to clear HCM diagnosis in 44.7% of patients. • In patients with a history of uncontrolled hypertension suspected, based on an echocardiogram, of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis.

Indexed as

Cardiomyopathy, HypertrophicEchocardiographyFemaleHeartHumansHypertrophy, Left VentricularMagnetic Resonance SpectroscopyMaleMiddle AgedEchocardiographyHypertensionHypertrophic cardiomyopathyMagnetic resonance imagingUltrasonography

Identifiers

PMID32876838
PMCPMC7880911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.